ID   KP-N-AY
AC   CVCL_9508
SY   Kyoto Pediatrics-Neuroblastoma-AY
DR   CGH-DB; 9086-4
DR   Cosmic; 848938
DR   Wikidata; Q54900386
RX   CelloPub=CLPUB00582;
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=2004854;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9509 ! KP-N-AYR
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
RX   CelloPub=CLPUB00582;
RA   Sugimoto T., Kuroda H., Yagyu S., Gotoh T., Osone S., Tamura S.,
RA   Iehara T., Hosoi H.;
RT   "Cellular and molecular characteristics of established neuroblastoma
RT   cell lines.";
RL   J. Cancer Res. Therap. Oncol. 7:201.1-201.15(2019).
//
RX   DOI=10.1007/0-306-46872-7_2;
RA   Thiele C.J.;
RT   "Neuroblastoma.";
RL   (In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.21-53; Kluwer Academic Publishers; New York; USA (1999).
//
RX   PubMed=2004854; DOI=10.1002/ijc.2910470518;
RA   Kuroda H., Sugimoto T., Ueda K., Tsuchida S., Horii Y., Inazawa J.,
RA   Sato K., Sawada T.;
RT   "Different drug sensitivity in two neuroblastoma cell lines
RT   established from the same patient before and after chemotherapy.";
RL   Int. J. Cancer 47:732-737(1991).
//
RX   PubMed=12702577;
RA   Saito-Ohara F., Imoto I., Inoue J., Hosoi H., Nakagawara A.,
RA   Sugimoto T., Inazawa J.;
RT   "PPM1D is a potential target for 17q gain in neuroblastoma.";
RL   Cancer Res. 63:1876-1883(2003).
//
RX   PubMed=23268333; DOI=10.1016/j.canlet.2012.12.011;
RA   Sugimoto T., Gotoh T., Yagyu S., Kuroda H., Iehara T., Hosoi H.,
RA   Ohta S., Ohira M., Nakagawara A.;
RT   "A MYCN-amplified cell line derived from a long-term event-free
RT   survivor among our sixteen established neuroblastoma cell lines.";
RL   Cancer Lett. 331:115-121(2013).
//